Search
Corcept Therapeutics Inc
CORTAdd to Watchlist
78.225USD
-3.705-4.52%
Market hours 11/04, 14:12（ET）
8.46BMarket Cap
170.80P/E TTM
Today
-4.52%
5 Days
-10.69%
1 Month
-32.70%
6 Months
+52.13%
Year to Date
+124.78%
1 Year
+5.47%
Key Figures
83.685Open
84.190High
119.97KVolume
170.80P/E TTM
14.79P/E Dynamic
--Dividend TTM
0.11%Turnover Ratio
81.930Prev. Close
71.510Low
9.11MTurnover
59.88P/E Static
11.98P/B
0.00%Div Yield TTM
5.70%ROA
126.38352wk High
0.12Volume Ratio
141.21MNet Profit
108.10MShares
0.4580EPS TTM
0.46Beta
7.17%ROE
28.66052wk Low
15.48%Amplitude
98.65%Gross Margin
8.46BMarket Cap
7.29Reward/Risk
5.26%Risk Rate
Corcept Therapeutics Inc's Score
0.03vs previous score
Forecast7.33
Financial Health8.80
Technical5.65
Valuation Dimensions7.01
Institutional Confidence7.00
Risk Assessment4.10
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Corcept Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Corcept Therapeutics Inc Latest Earnings Call Transcripts
Corcept Therapeutics (CORT) Q3 2026 Earnings Call: Revenue Rises 64%, Guidance Reaffirmed
Corcept Therapeutics Q3 2026 revenue rose 64% to $340.5 million as Lifyorli reached $91.4 million. CORT reiterated $1.1-$1.2 billion guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
1.17/0.79
Revenue / Forecast
340.47M/336.37M
Corcept Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolCORT
Number of employees500
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 10.29% |
| Ingalls & Snyder LLC (Asset Management) | 6.70% |
| Renaissance Technologies LLC | 5.36% |
| Baker (George Leonard Jr.) | 5.17% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 39.82% |
| Investment Advisor/Hedge Fund | 20.06% |
| Individual Investor | 11.79% |
| Hedge Fund | 8.15% |
Related Instruments
+1.09%
+3.52%
+2.12%
+2.72%
+3.42%
+2.61%
+3.77%
+4.55%
+6.33%
+2.08%
+3.50%
+2.43%
+3.80%
+4.49%
+5.07%
-2.64%
+7.45%
+1.21%
+2.64%
+2.72%Popular Instruments
53366.700
+1605.600 (+3.10%)
28575.700
+403.900 (+1.43%)
7712.000
+144.900 (+1.92%)
12797.000
-1.000 (-0.01%)
63104.000
+154.000 (+0.24%)
6311.000
+180.500 (+2.94%)
87.201
-8.707 (-9.08%)
352.615
+20.715 (+6.24%)
203.950
-2.740 (-1.33%)
4061.790
+140.490 (+3.58%)
FAQs
What is the current price of Corcept Therapeutics Inc (CORT)?
The current price of Corcept Therapeutics Inc (CORT) is 81.93.
What is the symbol of Corcept Therapeutics Inc?
The ticker symbol of Corcept Therapeutics Inc is CORT.
What is the 52-week high of Corcept Therapeutics Inc?
The 52-week high of Corcept Therapeutics Inc is 126.38.
What is the 52-week low of Corcept Therapeutics Inc?
The 52-week low of Corcept Therapeutics Inc is 28.66.
What is the market capitalization of Corcept Therapeutics Inc?
The market capitalization of Corcept Therapeutics Inc is 8.86B.
Is Corcept Therapeutics Inc (CORT) currently rated as Buy, Hold, or Sell?
According to analysts, Corcept Therapeutics Inc (CORT) has an overall rating of Buy, with a price target of 138.79.
What is the Earnings Per Share (EPS TTM) of Corcept Therapeutics Inc (CORT)?
The Earnings Per Share (EPS TTM) of Corcept Therapeutics Inc (CORT) is 0.46.